These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8139147)

  • 41. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
    Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studies of urinary proteins, FDP (fibrinogen degradation products), and NAG (N-acetyl-beta-D-glucosaminidase) in renal transplanted patients].
    Kunikata S; Ikegami M; Imanishi M; Nishioka T; Ishii T; Uemura T; Kanda H; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1989 Aug; 35(8):1299-304. PubMed ID: 2816597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary fibrin degradation products--a three year comparative study.
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Proc Eur Dial Transplant Assoc; 1978; 15():466-72. PubMed ID: 368788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrin deposits in the glomeruli and fibrin/fibrinogen degradation products (FDP) in the blood and urine in some renal diseases.
    Tishkov I; Tschoukanov C; Doytshinov D; Shipkova P
    Int Urol Nephrol; 1982; 14(1):89-93. PubMed ID: 7118491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [ Products of fibrin degradation in the urine during experimental and human glomerulonephritis].
    Lagrue G; Hirbec G; Gouault-Heilmann M; Levent M; Branellec A; Moisy M
    Pathol Biol (Paris); 1975 Jun; 23(6):486-91. PubMed ID: 1105353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical significance of urinary fibrin-fibrinogen degradation products in renal disease].
    Umitsu Y
    Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):371-87. PubMed ID: 988340
    [No Abstract]   [Full Text] [Related]  

  • 48. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary fibrin/fibrinogen degradation products measured using an anti-fibrinogen antibody predict orthostatic proteinuria.
    Kanai H; Sawanobori E; Kobayashi A; Goto M; Higashida K; Sugita K
    Pediatr Int; 2018 Jul; 60(7):639-644. PubMed ID: 29654610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
    Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On the origin of urinary fibrin-fibrinogen-related antigen in glomerulonephritis.
    Bone JM; Sherman LA; Valdes AJ; Lubowitz H
    J Lab Clin Med; 1977 May; 89(5):1043-52. PubMed ID: 558266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishment of a sandwich ELISA for human megsin, a kidney-specific serine protease inhibitor.
    Inagi R; Izuhara Y; Tominaga N; Nangaku M; Kurokawa K; Miyata T
    Nephrol Dial Transplant; 2007 Nov; 22(11):3311-7. PubMed ID: 17595191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Fibrin degradation products in the urine in renal diseases].
    Iversen BM; Ofstad J; Thunold S; Willassen Y
    Tidsskr Nor Laegeforen; 1976 Jan; 96(2):91-3. PubMed ID: 766292
    [No Abstract]   [Full Text] [Related]  

  • 54. [On coagulation and fibrinolysis in renal diseases, with special reference to FDP subfragment and urinary plasmin body].
    Nakamichi S
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):353-66. PubMed ID: 6236317
    [No Abstract]   [Full Text] [Related]  

  • 55. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria.
    Takahagi S; Mihara S; Iwamoto K; Morioke S; Okabe T; Kameyoshi Y; Hide M
    Allergy; 2010 May; 65(5):649-56. PubMed ID: 19845571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Urinary-plasmin alpha 2 plasmin inhibitor complex (PIC) in patients with diabetic nephropathy].
    Saigo K; Ryo R; Yamaguchi N
    Rinsho Byori; 1993 Jul; 41(7):785-8. PubMed ID: 8361049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Studies on fibrinolytic therapy in children with various renal diseases with special reference to changes of urinary FDP x D-dimer fragments].
    Kamitsuji H; Iida Y; Omura R; Taira K; Tsukada S; Kusumoto K; Okamoto Y
    Nihon Jinzo Gakkai Shi; 1982 Nov; 24(11):1251-9. PubMed ID: 7166891
    [No Abstract]   [Full Text] [Related]  

  • 58. Fibrinogen and fibrinogen/fibrin degradation products in the urine of rabbits infected with Trypanosoma (trypanozoon) brucei.
    Boreham PF; Facer CA
    Z Parasitenkd; 1977 Jul; 52(3):257-65. PubMed ID: 906631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The kidney and fibrinolysis. (2) Urinary excretion of FDP].
    Taura K; Fukushima K; Shinzato K; Harada T; Ogata H
    Nihon Jinzo Gakkai Shi; 1977 Mar; 19(3):139-49. PubMed ID: 560577
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of intrarenal coagulation and anticoagulant therapy in the progression of diabetic nephropathy.
    Kaizu K; Uriu K; Hashimoto O; Morita E; Eto S; Suzuki H
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):35-42. PubMed ID: 8336398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.